GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Asset Impairment Charge

WuXi XDC Cayman (HKSE:02268) Asset Impairment Charge : HK$0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Asset Impairment Charge?

WuXi XDC Cayman's Asset Impairment Charge for the six months ended in Jun. 2024 was HK$0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

WuXi XDC Cayman Asset Impairment Charge Historical Data

The historical data trend for WuXi XDC Cayman's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Asset Impairment Charge Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
- - - -

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

WuXi XDC Cayman Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

WuXi XDC Cayman Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Asset Impairment Charge
Comparable Companies
Traded in Other Exchanges
L74:Germany
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
https://www.wuxixdc.com
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Executives
Wuxi Biologics (cayman) Inc. 2101 Beneficial owner
Wuxi Apptec Co., Ltd.
Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si

WuXi XDC Cayman Headlines

No Headlines